We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Alizé Pharma II Sign Licensing Agreement with EUSA Pharma

Product News   Feb 03, 2012

 
Alizé Pharma II Sign Licensing Agreement with EUSA Pharma
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Formedix Announces Expansion to Meet Demands for Clinical Trial Automation

Product News

Formedix, announces expansion of its development and test teams. By expanding the workforce, Formedix can stay abreast of technological breakthroughs and meet greater client demands for the enhancement and advancement of its platform.

READ MORE

Biopharma Receives Positive EMA Opinion on Orphan Designation for Pancreatic Cancer Treatment

Product News

Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP) has granted a positive opinion for an Orphan Drug Designation (ODD) status to its first-in-class anti-PAUF monoclonal antibody, PBP1510, for the treatment of pancreatic cancer.

READ MORE

REGN-COV2 Antibody Cocktail Reduced Viral Load and Alleviated Symptoms in Non-Hospitalized COVID-19 Patients

Product News

Regeneron has announced the first data from a descriptive analysis of a Phase 1/2/3 trial of the investigational antibody cocktail known as "REGN-COV2". Results show that it reduced viral load and alleviated symptoms in non-hospitalized patients with COVID-19.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE